(PQD6) Hypothalamic Inflammation in the Initiation of Cachexia

(PQD6) 恶病质引发的下丘脑炎症

基本信息

  • 批准号:
    9079439
  • 负责人:
  • 金额:
    $ 42.24万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-07-01 至 2018-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Cachexia, or disease-associated wasting, is a common occurrence in cancer, renal failure, and infectious disease. This devastating state of malnutrition is brought about by a synergistic combination of a decrease in appetite and an increase in metabolism of fat and lean body mass. The severity of cachexia in many illnesses is the primary determining factor in both quality of life, and in eventual mortality. Other illness-induced morbidities including lethargy also compromise the ability of patients to recover from potentially life-saving or extending interventions, and diminish the motivational drive to aggressively battle the condition. Although cachexia in chronic disease was described more than two thousand years ago, the central mechanisms underlying this disorder of energy homeostasis are poorly understood. Furthermore, there is currently no effective pharmaceutical treatment. Our laboratory has dedicated the last decade to unraveling the basic neuroscience of cachexia. In this proposal, we will focus on understanding the scope and mechanism by which peripheral inflammatory insults are received, amplified, and maintained by the hypothalamus. The significance of this proposal resides in its unique combination of our historical focus on neuroendocrinology and behavior, with new collaborations and efforts directed at understanding proximal neuroinflammatory events. The long-term goal of our research is to gain mechanistic understanding of the acute illness response and how it is transitioned into chronic inflammation-associated cachexia in order to develop more effective therapeutic interventions.
描述(由申请人提供):恶病质或疾病相关性消瘦在癌症、肾衰竭和感染性疾病中常见。这种破坏性的营养不良状态是由食欲下降和脂肪和瘦体重代谢增加的协同组合带来的。在许多疾病中,恶病质的严重程度是生活质量和最终死亡率的主要决定因素。包括嗜睡在内的其他疾病引起的发病率也损害了患者从潜在的挽救生命或延长干预措施中恢复的能力,并削弱了积极对抗病情的动力。虽然早在两千多年前就有人描述过慢性疾病中的恶病质,但对这种能量稳态紊乱的中枢机制却知之甚少。此外,目前还没有有效的药物治疗。我们的实验室在过去的十年里致力于揭示恶病质的基础神经科学。在这个建议中,我们将集中在了解的范围和机制,外周炎症损伤的接收,放大,并保持下丘脑。这项提议的意义在于它独特地结合了我们对神经内分泌学和行为的历史关注,以及针对理解近端神经炎症事件的新合作和努力。我们研究的长期目标是获得对急性疾病反应的机制性理解,以及它如何转变为慢性炎症相关的恶病质,以开发更有效的治疗干预措施。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Daniel L. Marks其他文献

Serum leptin levels, hepatic leptin receptor transcription, and clinical predictors of non-alcoholic steatohepatitis in obese bariatric surgery patients
肥胖减肥手术患者的血清瘦素水平、肝脏瘦素受体转录和非酒精性脂肪性肝炎的临床预测因子
  • DOI:
  • 发表时间:
    2007
  • 期刊:
  • 影响因子:
    0
  • 作者:
    D. Le;Daniel L. Marks;E. Lyle;Christopher L. Corless;B. Diggs;B. A. Jobe;Tom S. Kay;Clifford W. Deveney;Bruce M. Wolfe;C. Roberts;Robert W. O’Rourke
  • 通讯作者:
    Robert W. O’Rourke
Rapid prototyping lightweight millimeter wave antenna and waveguide with copper plating
快速原型制作轻型毫米波天线和镀铜波导

Daniel L. Marks的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Daniel L. Marks', 18)}}的其他基金

PQ6: Therapeutic approaches for autonomic and neuroendocrine dysfunction in cancer cachexia
PQ6:癌症恶病质自主神经和神经内分泌功能障碍的治疗方法
  • 批准号:
    10303658
  • 财政年份:
    2021
  • 资助金额:
    $ 42.24万
  • 项目类别:
PQ6: Lipocalin-2 as a therapeutic target for prevention of cancer cachexia
PQ6:Lipocalin-2 作为预防癌症恶病质的治疗靶点
  • 批准号:
    10379260
  • 财政年份:
    2021
  • 资助金额:
    $ 42.24万
  • 项目类别:
PQ6: Lipocalin-2 as a therapeutic target for prevention of cancer cachexia
PQ6:Lipocalin-2 作为预防癌症恶病质的治疗靶点
  • 批准号:
    10152268
  • 财政年份:
    2021
  • 资助金额:
    $ 42.24万
  • 项目类别:
PQ6: Therapeutic approaches for autonomic and neuroendocrine dysfunction in cancer cachexia
PQ6:癌症恶病质自主神经和神经内分泌功能障碍的治疗方法
  • 批准号:
    10490306
  • 财政年份:
    2021
  • 资助金额:
    $ 42.24万
  • 项目类别:
Exosomes as Endocrine Signaling Molecules in Cancer Cachexia
外泌体作为癌症恶病质的内分泌信号分子
  • 批准号:
    9906180
  • 财政年份:
    2018
  • 资助金额:
    $ 42.24万
  • 项目类别:
Exosomes as Endocrine Signaling Molecules in Cancer Cachexia
外泌体作为癌症恶病质的内分泌信号分子
  • 批准号:
    10171402
  • 财政年份:
    2018
  • 资助金额:
    $ 42.24万
  • 项目类别:
Exosomes as Endocrine Signaling Molecules in Cancer Cachexia
外泌体作为癌症恶病质的内分泌信号分子
  • 批准号:
    10394305
  • 财政年份:
    2018
  • 资助金额:
    $ 42.24万
  • 项目类别:
(PQD6) Hypothalamic Inflammation in the Initiation of Cachexia
(PQD6) 恶病质引发的下丘脑炎症
  • 批准号:
    8994016
  • 财政年份:
    2014
  • 资助金额:
    $ 42.24万
  • 项目类别:
(PQD6) Hypothalamic Inflammation in the Initiation of Cachexia
(PQD6) 恶病质引发的下丘脑炎症
  • 批准号:
    8845181
  • 财政年份:
    2014
  • 资助金额:
    $ 42.24万
  • 项目类别:
(PQD6) Hypothalamic Inflammation in the Initiation of Cachexia
(PQD6) 恶病质引发的下丘脑炎症
  • 批准号:
    8680933
  • 财政年份:
    2014
  • 资助金额:
    $ 42.24万
  • 项目类别:

相似海外基金

Role of hypothalamic MC4R in glucose homeostasis via a novel neuroendocrine circuit involving the kidneys and adrenal glands
下丘脑 MC4R 通过涉及肾脏和肾上腺的新型神经内分泌回路在葡萄糖稳态中的作用
  • 批准号:
    10454300
  • 财政年份:
    2021
  • 资助金额:
    $ 42.24万
  • 项目类别:
Role of hypothalamic MC4R in glucose homeostasis via a novel neuroendocrine circuit involving the kidneys and adrenal glands
下丘脑 MC4R 通过涉及肾脏和肾上腺的新型神经内分泌回路在葡萄糖稳态中的作用
  • 批准号:
    10666539
  • 财政年份:
    2021
  • 资助金额:
    $ 42.24万
  • 项目类别:
Role of hypothalamic MC4R in glucose homeostasis via a novel neuroendocrine circuit involving the kidneys and adrenal glands
下丘脑 MC4R 通过涉及肾脏和肾上腺的新型神经内分泌回路在葡萄糖稳态中的作用
  • 批准号:
    10296199
  • 财政年份:
    2021
  • 资助金额:
    $ 42.24万
  • 项目类别:
Role of hypothalamic MC4R in glucose homeostasis via a novel neuroendocrine circuit involving the kidneys and adrenal glands
下丘脑 MC4R 通过涉及肾脏和肾上腺的新型神经内分泌回路在葡萄糖稳态中的作用
  • 批准号:
    10854123
  • 财政年份:
    2021
  • 资助金额:
    $ 42.24万
  • 项目类别:
Interaction of adrenal glands and liver in canine hepatocellular carcinoma
犬肝细胞癌中肾上腺和肝脏的相互作用
  • 批准号:
    20H03139
  • 财政年份:
    2020
  • 资助金额:
    $ 42.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Role of dendritic cells in adrenal glands of healthy and arthritic rats
树突状细胞在健康和关节炎大鼠肾上腺中的作用
  • 批准号:
    235438724
  • 财政年份:
    2013
  • 资助金额:
    $ 42.24万
  • 项目类别:
    Research Grants
Role of neural cell adhesion molecules in structural and functional remodeling of fetal adrenal glands
神经细胞粘附分子在胎儿肾上腺结构和功能重塑中的作用
  • 批准号:
    20591305
  • 财政年份:
    2008
  • 资助金额:
    $ 42.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Search for the novel etiology in disorders of sex development (DSD) caused by abnormalities of adrenal glands and gonads.
寻找由肾上腺和性腺异常引起的性发育障碍 (DSD) 的新病因。
  • 批准号:
    16086202
  • 财政年份:
    2004
  • 资助金额:
    $ 42.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research on Priority Areas
Effects of endocrine disrupters on function of thyroid gland, adrenal glands and gonads
内分泌干​​扰物对甲状腺、肾上腺和性腺功能的影响
  • 批准号:
    11839003
  • 财政年份:
    1999
  • 资助金额:
    $ 42.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Roles of Thyroid and Adrenal glands in the regulation of hypothalamo-hypophysial-ovarian axis in the rat.
甲状腺和肾上腺在大鼠下丘脑-垂体-卵巢轴调节中的作用。
  • 批准号:
    06660375
  • 财政年份:
    1994
  • 资助金额:
    $ 42.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了